Evolent Health (EVH) Interest Expenses (2016 - 2026)

Evolent Health's Interest Expenses history runs 11 years deep, the most recent figure standing at $16.9 million for Q1 2026.

• In Q1 2026, Interest Expenses rose 62.43% year-over-year to $16.9 million; the TTM figure through Mar 2026 stood at $64.0 million (up 119.7% YoY), while the FY2025 annual figure was $57.5 million, up 132.47% from the prior year.
• Interest Expenses was $16.9 million for Q1 2026 at Evolent Health, down from $19.0 million in the prior quarter.
• In the past five years, Interest Expenses ranged from a high of $19.0 million in Q4 2025 to a low of $2.1 million in Q2 2022.
• Historically, Interest Expenses has averaged $9.9 million across 5 years, with a median of $10.4 million in 2025.
• The sharpest annual moves came in 2022 and 2023: Interest Expenses tumbled 65.76% in 2022, then soared 573.09% in 2023.
• A 5-year view of Interest Expenses shows it stood at $6.4 million in 2022, then soared by 90.36% to $12.2 million in 2023, then plunged by 45.09% to $6.7 million in 2024, then soared by 182.89% to $19.0 million in 2025, then dropped by 11.27% to $16.9 million in 2026.
• The last three Interest Expenses figures came in at $16.9 million (Q1 2026), $19.0 million (Q4 2025), and $16.5 million (Q3 2025), per Business Quant data.